Pharmaceutical and Healthcare Industry in Ukraine - Forecast and Analysis 2021
Ukraine is still struggling to control the COVID-19 pandemic, but with approval of the Johnson & Johnson coronavirus vaccine along with vaccines from Pfizer and AstraZeneca, it is expected that the increasing vaccination of its population should make a difference and control the spread of the outbreak.
The pharmaceutical industry in Ukraine is amongst the ten biggest pharmaceutical industries in the Central and Eastern European (CEE) region. With the country adopting new healthcare reform bills from January 2018, the overall outlook for the healthcare and pharmaceutical industry has improved considerably. Both pharmaceutical and healthcare spending is expected to increase in the coming years as the lockdown restrictions are eased, and COVID-19 related vaccine purchases drive up the demand for associated services.
Up until 2014, the Ukrainian pharmaceutical industry was primarily dominated by foreign companies. However, in recent years, Ukrainian companies are making their mark felt in the sector, with Farmak International and Arterium Corporation emerging as the leading industry players.
Aruvian Research presents an in-depth analysis of the Pharmaceutical and Healthcare Industry of Ukraine in its research report Pharmaceutical and Healthcare Industry in Ukraine – Forecast and Analysis 2021. The report covers the following data:
The pharmaceutical industry in Ukraine is amongst the ten biggest pharmaceutical industries in the Central and Eastern European (CEE) region. With the country adopting new healthcare reform bills from January 2018, the overall outlook for the healthcare and pharmaceutical industry has improved considerably. Both pharmaceutical and healthcare spending is expected to increase in the coming years as the lockdown restrictions are eased, and COVID-19 related vaccine purchases drive up the demand for associated services.
Up until 2014, the Ukrainian pharmaceutical industry was primarily dominated by foreign companies. However, in recent years, Ukrainian companies are making their mark felt in the sector, with Farmak International and Arterium Corporation emerging as the leading industry players.
Aruvian Research presents an in-depth analysis of the Pharmaceutical and Healthcare Industry of Ukraine in its research report Pharmaceutical and Healthcare Industry in Ukraine – Forecast and Analysis 2021. The report covers the following data:
- An in-depth coverage of the pharmaceutical and healthcare industry in Ukraine by sectors along with an analysis of how the COVID-19 pandemic is effecting the industry.
- We analyze the segments of prescription drugs, generic drugs, OTC medicines, and also analyze the landscape for clinical trials in Ukraine.
- A SWOT analysis of the Ukrainian pharmaceutical and healthcare industry.
- We take an up-close view of the regulatory framework governing the Ukrainian pharmaceutical and healthcare industry.
- Competition in the industry, along with an in-depth analysis of the major domestic and multinational players like Farmac, Arterium Corporation, AstraZeneca, Eli Lilly, Glaxo Smith Kline, and many others are included.
A. EXECUTIVE SUMMARY
B. INDUSTRY DEFINITION
C. Pharmaceutical & Healthcare Industry in Ukraine
C.1 Industry Overview
C.2 Impact of COVID-19 on the Industry
C.3 Pharmaceutical Sector Analysis
C.4 Healthcare Sector Analysis
C.5 Healthcare Reforms
C.6 Market for Prescription Drugs
C.7 Market for Patented Drugs
C.8 Market for OTC Medicines
C.9 Market for Generic Drugs
C.10 Research & Development in the Industry
C.11 Clinical Trials in Ukraine
D. UKRAINE PHARMACEUTICAL & HEALTHCARE INDUSTRY: SWOT ANALYSIS
D.1 Strengths to Build Upon
D.2 Weaknesses to Overcome
D.3 Opportunities to Exploit
D.4 Threats to Overcome
E. CHRONIC MEDICAL CONDITIONS IN UKRAINE
E.1 Overview
E.2 Cancer
E.3 Cardiovascular Diseases
E.4 Diabetes
E.5 HIV/AIDS
E.6 Respiratory Diseases
F. REGULATORY FRAMEWORK OF THE INDUSTRY
F.1 Regulatory Landscape
F.2 Regulations for Medicine Pricing
F.3 Regulations for Medicine Reimbursement
F.4 Challenges with Counterfeit Drugs
F.5 Challenges with Intellectual Property Rights
F.6 Regulations governing Promotion of Pharmaceuticals
G. IMPORT/EXPORT OF PHARMACEUTICALS
H. COMPETITION IN THE INDUSTRY
H.1 Competitive Landscape
H.2 Impacts on Competition
H.3 Competition in the Generic Drugs Sector
H.4 Competition in the Ukraine Pharmacy Sector
H.5 Competition in the Drug Distribution Market
I. FORECAST: PHARMACEUTICAL & HEALTHCARE INDUSTRY IN UKRAINE
I.1 Outlook of the Pharmaceutical Industry in Ukraine
I.2 Outlook of the Healthcare Industry in Ukraine
I.3 Outlook for Prescription Drugs Sector
I.4 Outlook for Patented Drugs Market
I.5 Outlook for OTC Medicine Market
I.6 Outlook for the Generic Drugs Market
J. MAJOR DOMESTIC & MULTINATIONAL PLAYERS
J.1 Arterium Corporation
J.1.1 Corporate Analysis
J.1.2 Business Segment Analysis
J.1.3 Financial Analysis
J.1.4 SWOT Analysis
J.2 Farmak International
J.2.1 Corporate Analysis
J.2.2 Business Segment Analysis
J.2.3 Financial Analysis
J.2.4 SWOT Analysis
J.3 AbbVie
J.3.1 Corporate Analysis
J.3.2 Business Segment Analysis
J.3.3 Financial Analysis
J.3.4 SWOT Analysis
J.4 AstraZeneca
J.4.1 Corporate Analysis
J.4.2 Business Segment Analysis
J.4.3 Financial Analysis
J.4.4 SWOT Analysis
J.5 GlaxoSmithKline
J.5.1 Corporate Analysis
J.5.2 Business Segment Analysis
J.5.3 Financial Analysis
J.5.4 SWOT Analysis
J.6 Johnson & Johnson
J.6.1 Corporate Analysis
J.6.2 Business Segment Analysis
J.6.3 Financial Analysis
J.6.4 SWOT Analysis
J.7 Merck & Co
J.7.1 Corporate Analysis
J.7.2 Business Segment Analysis
J.7.3 Financial Analysis
J.7.4 SWOT Analysis
J.8 Novartis
J.8.1 Corporate Analysis
J.8.2 Business Segment Analysis
J.8.3 Financial Analysis
J.8.4 SWOT Analysis
J.9 Pfizer
J.9.1 Corporate Analysis
J.9.2 Business Segment Analysis
J.9.3 Financial Analysis
J.9.4 SWOT Analysis
J.10 Sanofi SA
J.10.1 Corporate Analysis
J.10.2 Business Segment Analysis
J.10.3 Financial Analysis
J.10.4 SWOT Analysis
J.11 Takeda Pharmaceutical
J.11.1 Corporate Analysis
J.11.2 Business Segment Analysis
J.11.3 Financial Analysis
J.11.4 SWOT Analysis
K. GLOSSARY OF TERMS
L. RESEARCH METHODOLOGY
M. DISCLAIMER
B. INDUSTRY DEFINITION
C. Pharmaceutical & Healthcare Industry in Ukraine
C.1 Industry Overview
C.2 Impact of COVID-19 on the Industry
C.3 Pharmaceutical Sector Analysis
C.4 Healthcare Sector Analysis
C.5 Healthcare Reforms
C.6 Market for Prescription Drugs
C.7 Market for Patented Drugs
C.8 Market for OTC Medicines
C.9 Market for Generic Drugs
C.10 Research & Development in the Industry
C.11 Clinical Trials in Ukraine
D. UKRAINE PHARMACEUTICAL & HEALTHCARE INDUSTRY: SWOT ANALYSIS
D.1 Strengths to Build Upon
D.2 Weaknesses to Overcome
D.3 Opportunities to Exploit
D.4 Threats to Overcome
E. CHRONIC MEDICAL CONDITIONS IN UKRAINE
E.1 Overview
E.2 Cancer
E.3 Cardiovascular Diseases
E.4 Diabetes
E.5 HIV/AIDS
E.6 Respiratory Diseases
F. REGULATORY FRAMEWORK OF THE INDUSTRY
F.1 Regulatory Landscape
F.2 Regulations for Medicine Pricing
F.3 Regulations for Medicine Reimbursement
F.4 Challenges with Counterfeit Drugs
F.5 Challenges with Intellectual Property Rights
F.6 Regulations governing Promotion of Pharmaceuticals
G. IMPORT/EXPORT OF PHARMACEUTICALS
H. COMPETITION IN THE INDUSTRY
H.1 Competitive Landscape
H.2 Impacts on Competition
H.3 Competition in the Generic Drugs Sector
H.4 Competition in the Ukraine Pharmacy Sector
H.5 Competition in the Drug Distribution Market
I. FORECAST: PHARMACEUTICAL & HEALTHCARE INDUSTRY IN UKRAINE
I.1 Outlook of the Pharmaceutical Industry in Ukraine
I.2 Outlook of the Healthcare Industry in Ukraine
I.3 Outlook for Prescription Drugs Sector
I.4 Outlook for Patented Drugs Market
I.5 Outlook for OTC Medicine Market
I.6 Outlook for the Generic Drugs Market
J. MAJOR DOMESTIC & MULTINATIONAL PLAYERS
J.1 Arterium Corporation
J.1.1 Corporate Analysis
J.1.2 Business Segment Analysis
J.1.3 Financial Analysis
J.1.4 SWOT Analysis
J.2 Farmak International
J.2.1 Corporate Analysis
J.2.2 Business Segment Analysis
J.2.3 Financial Analysis
J.2.4 SWOT Analysis
J.3 AbbVie
J.3.1 Corporate Analysis
J.3.2 Business Segment Analysis
J.3.3 Financial Analysis
J.3.4 SWOT Analysis
J.4 AstraZeneca
J.4.1 Corporate Analysis
J.4.2 Business Segment Analysis
J.4.3 Financial Analysis
J.4.4 SWOT Analysis
J.5 GlaxoSmithKline
J.5.1 Corporate Analysis
J.5.2 Business Segment Analysis
J.5.3 Financial Analysis
J.5.4 SWOT Analysis
J.6 Johnson & Johnson
J.6.1 Corporate Analysis
J.6.2 Business Segment Analysis
J.6.3 Financial Analysis
J.6.4 SWOT Analysis
J.7 Merck & Co
J.7.1 Corporate Analysis
J.7.2 Business Segment Analysis
J.7.3 Financial Analysis
J.7.4 SWOT Analysis
J.8 Novartis
J.8.1 Corporate Analysis
J.8.2 Business Segment Analysis
J.8.3 Financial Analysis
J.8.4 SWOT Analysis
J.9 Pfizer
J.9.1 Corporate Analysis
J.9.2 Business Segment Analysis
J.9.3 Financial Analysis
J.9.4 SWOT Analysis
J.10 Sanofi SA
J.10.1 Corporate Analysis
J.10.2 Business Segment Analysis
J.10.3 Financial Analysis
J.10.4 SWOT Analysis
J.11 Takeda Pharmaceutical
J.11.1 Corporate Analysis
J.11.2 Business Segment Analysis
J.11.3 Financial Analysis
J.11.4 SWOT Analysis
K. GLOSSARY OF TERMS
L. RESEARCH METHODOLOGY
M. DISCLAIMER
LIST OF FIGURES
Figure 1: Growth of the Pharmaceutical Sales in Ukraine, 2016-2030
Figure 2: Clinical Trials in Ukraine
Figure 3: Import-Export of Pharmaceuticals in Ukraine (in UAH Million), 2016-2025
Figure 4: Expenditure on Healthcare in Ukraine, 2016-2030
Figure 5: Forecast of the Prescription Drug Market in Ukraine, 2016-2030
Figure 6: Forecast of the Patented Drugs Sector in Ukraine, 2016-2030
Figure 7: Forecast of the OTC Medicine Market in Ukraine, 2016-2030
Figure 8: Forecast of the Generic Drug Market in Ukraine, 2016-2030
Figure 1: Growth of the Pharmaceutical Sales in Ukraine, 2016-2030
Figure 2: Clinical Trials in Ukraine
Figure 3: Import-Export of Pharmaceuticals in Ukraine (in UAH Million), 2016-2025
Figure 4: Expenditure on Healthcare in Ukraine, 2016-2030
Figure 5: Forecast of the Prescription Drug Market in Ukraine, 2016-2030
Figure 6: Forecast of the Patented Drugs Sector in Ukraine, 2016-2030
Figure 7: Forecast of the OTC Medicine Market in Ukraine, 2016-2030
Figure 8: Forecast of the Generic Drug Market in Ukraine, 2016-2030
LIST OF TABLES
Table 1: Growth of the Pharmaceutical Sales in Ukraine, 2016-2030
Table 2: Healthcare Resources in Ukraine, 2015-2020
Table 3: Inpatient/Outpatient Statistics in Ukraine, 2015-2020
Table 4: Personnel in Ukraine's Healthcare Sector, 2015-2020
Table 5: Medicines under Ukraine's Affordable Medicines Program
Table 6: Import-Export of Pharmaceuticals in Ukraine (in UAH Million), 2019-2025
Table 7: Import-Export of Pharmaceuticals in Ukraine (in USD Million), 2019-2025
Table 8: Members of AIPM Ukraine as of 2020
Table 9: Statistics of the Pharmaceutical & Healthcare Industry in Ukraine, 2019-2025
Table 10: Expenditure on Healthcare in Ukraine, 2016-2030
Table 11: Government Expenditure on Healthcare in Ukraine, 2017-2025
Table 12: Healthcare Expenditure by Private Sector on Healthcare in Ukraine, 2017-2025
Table 13: Forecast of the Prescription Drug Market in Ukraine, 2016-2030
Table 14: Forecast of the Patented Drugs Sector in Ukraine, 2017-2025
Table 15: Forecast of the OTC Medicine Market in Ukraine, 2017-2025
Table 16: Forecast of the Generic Drug Market in Ukraine, 2017-2025
Table 1: Growth of the Pharmaceutical Sales in Ukraine, 2016-2030
Table 2: Healthcare Resources in Ukraine, 2015-2020
Table 3: Inpatient/Outpatient Statistics in Ukraine, 2015-2020
Table 4: Personnel in Ukraine's Healthcare Sector, 2015-2020
Table 5: Medicines under Ukraine's Affordable Medicines Program
Table 6: Import-Export of Pharmaceuticals in Ukraine (in UAH Million), 2019-2025
Table 7: Import-Export of Pharmaceuticals in Ukraine (in USD Million), 2019-2025
Table 8: Members of AIPM Ukraine as of 2020
Table 9: Statistics of the Pharmaceutical & Healthcare Industry in Ukraine, 2019-2025
Table 10: Expenditure on Healthcare in Ukraine, 2016-2030
Table 11: Government Expenditure on Healthcare in Ukraine, 2017-2025
Table 12: Healthcare Expenditure by Private Sector on Healthcare in Ukraine, 2017-2025
Table 13: Forecast of the Prescription Drug Market in Ukraine, 2016-2030
Table 14: Forecast of the Patented Drugs Sector in Ukraine, 2017-2025
Table 15: Forecast of the OTC Medicine Market in Ukraine, 2017-2025
Table 16: Forecast of the Generic Drug Market in Ukraine, 2017-2025
